ArticleVeterinary research communications2026
Case report: an atypical case of EBLV-1 infection in the long distance migrant bat Pipistrellus nathusii in mainland France.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver the past five decades, nearly 1,500 bat rabies cases have been reported in Europe. The majority of positive cases (with 90% of cases) originated from Germany, followed by The Netherlands, Denmark, Poland, France and Spain. Among the seven lyssaviruses detected in European bats, three different recognized species are circulating in some native bat species in France: EBLV-1, BBLV, and LLEBV, primarily associated with the host species Eptesicus serotinus, Myotis nattereri, and Miniopterus schreibersii, respectively. CASE PRESENTATION: In 2022, we reported an unusual case of EBLV-1 infection in a long-distance migrant bat species, Pipistrellus nathusii. The bat’s brain tested positive for the presence of viral antigens using the fluorescent antibody test (FAT) and for viral RNA through molecular techniques (including real-time and end-point pan-lyssavirus RT-PCR). In this study, we determined the nearly complete genome sequence of the virus using next-generation sequencing (PX733926). Molecular clock dating and phylogenetic analysis confirmed that the bat was infected with the EBLV-1a variant, the most common and widely distributed European bat lyssavirus. The virus genome showed 99.88% nucleotide similarity with a strain isolated from a serotine bat in the Lower Saxony region of Germany in 2016 (OU524432).
conclusionsThis finding is the first of its kind in France and the third in Europe involving a long-distance migrant bat. It may partially explain the extensive geographic distribution of EBLV-1a across Europe, following both east-west and north-south axes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.